1.25 semaglutide The FDA approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 This medication is used with a doctor Semaglutide diabetes medication packag |

, -

doi: 10.3389/fnut.2026.1804917 Received 05 February 2026 Revised 04 March 2026 Accepted 16 March 2026 Published 31 March 2026 Volume 13 - 2026 Edited by Berenice M Romn Calleja, National Institute of Medical Sciences and Nutrition Salvador Zubirn, Mexico Reviewed by Anindita Banerjee, Indian Council of Medical Research (ICMR), India Venkateswararao Eeda, University of Oklahoma Health Sciences Center, United States Updates Copyright 2026 Chen, Zou, Li, Liu, Liu, Yao, Peng, Liang, Chen, Huang and Huang

People who want to try semaglutide with B12 should compare it to these other treatments based on their health goals, how they want to take medicine, and which side effects they want to avoid

Kidney function is another important consideration

Since its US FDA approval in June 2021 and subsequent EU and Japan approval in 2022 and 2023, respectively, for chronic weight management, WEGOVY has rapidly gained traction